LEADING EDGE BIO

Artificial intelligence has advanced at an astonishing pace. Large language models (LLMs) can now draft scientific reports, summarize literature, analyze contracts, generate software code, and even assist with regulatory documentation. Yet despite these impressive capabilities, one critical challenge remains: how do organizations trust AI-generated outputs enough to make real business decisions? The answer is increasingly becoming clear. The future of enterprise AI is not sim

When Retro Biosciences emerged from stealth mode in mid-2022, it did so with a grand ambition: to extend the average human lifespan by a...

As we celebrate Independence Day, it's an opportune moment to reflect on the concept of freedom from a unique perspective: the freedom to...